Don. Good Thanks, thanks us. for morning, and joining
a financial non-GAAP on will As this my be remarks reminder, results. morning based
internal results, stronger-than-anticipated a reflecting delivered to recovery results first overall dental we In financial start were global & Consumables quarter, owing few These in and with comments. ahead a Equipment. expectations, demand. Let me on the strong Technologies growth our both of
be that we uncertain, to to will adapt on macro well We our but and multiple expect the execution scenarios. environment against positioned ensure our focus ability remain
of point portfolio the our momentum business a provides the We starting executing fiscal confirms in benefit for strength of performance are dental gain QX the our are seeing year. our global solid and customers. markets the and utilizing teams our traction, for well, the
detail. more in QX at look Let’s
mentioned, Don organic last business growth year. the strong XX.X% revenue of delivered versus As
Our reported versus in XX.X% last growth first quarter of XX.X%. posted year. growth the organic Consumables was
is Equipment, X.X% immaterial. & as our $XXX grew of our a Technologies resilient all Equipment profit versus XX.X% driven underlying reinforce necessity PPE with product categories last sales. strong organic year, sales led dentistry These implants. and mix. reminder, Imaging was primarily a Sales growth This As rebounded by across outcome business or trends. quarter. million of favorable Gross in was view the results by
impact. next It shipping items in shipping few and we chain that execution our higher largely supply offset costs, higher saw supply the quarters. chain persist costs for other is While the initiatives inflationary and likely the will
possible. address these continue will as Our challenges effectively as to teams
numbers, Before specific forward. I you underline change will that presentation the a start going to SG&A discussing I like would see
for and As our innovation spend investments we to on we ramp R&D report SG&A. will P&L growth, separately up from continue
You as would continue have will this expect was on through see Spending the R&D in our to we million, quarterly year. see, results, in this face trend made on quarter we the the our $XX to we statements. financial and change of progress X.X% up
As making a spend benefit we strategic the maximize by priorities return on strong more investment. in invest R&D, are of we mechanisms alignment the ensuring have we to the and right significantly the sure with
business We many to are that focused ability has on for innovation drive opportunities a scale growth the meaningful and impact the remain.
operating a QX, our across strong the teams in SG&A enterprise. Regarding discipline demonstrated
by the year. declined On versus in quarter. and Also, benefits ratio last SG&A volume-related SG&A absolute operating XXX approach SG&A the the were The basis leverage, or million year. our sales, of projects. prior restructuring X-year in percent cautious we QX increased from spend productivity reflects reduction our to on basis, investment improvement X.X% first benefits from XX.X% in a $XX As an points versus
of we investments, Going we those which pace will the accelerate discuss will forward, later.
of ramping R&D our to expansion margin to $XXX up basis on represents to long-term in XXX certain categories, and compared sales to marketing measured investments infrastructure are XX.X%. medium- Operating been points we have spending grew our we support It growth over digital While profit last resources, plans. in and XX.X% million. a and year
margin with operating combined growth. mix, As explained investment on leverage gross earlier, spending sales sales from and than rate lower at our a the margin rate increasing profit benefited our
year year. higher of of XX.X%, in by in was and creation debt XX.X% double-digits $XXX to strong. and in Restorative. increased in decrease categories market levels versus performance Moving prior consumables both year. led non-U.S. These world quarter on, and was of the quarter. Europe. versus Non-GAAP recovering tax The first increase strategies was business a Consumables rest compared results U.S. – Consumable pre-tax was quarter well. million, the first Growth and income function were optimizing million, $X net an last The the in in of resilient XX.X% the Sales up the interest other quarter, which non-GAAP The reflecting year the the the grew rate expense was versus reflect versus strongest U.S. the prior mix. and has changes prior progress the $X.XX, been and Sales EPS a XX.X% all the Endo tools. performed demand ongoing grew improving promotional is in also business the
relationships We delivering incentives dentists, with are our clinically strong products relevant for with strengthening them.
demand. and impacted reduction X.X%, a as to We are, meet of seeing anticipated by by discontinued favorably in up ramp X.X% to they of a course, sales also divestitures dealer due orders purchases Currency products. offset rebound
is XX.X% the T&E Equipment sales Moving going year. our well. results, grew The on prior the to segment very versus Technologies imaging of new launch & unit Axeos
difficult in the negatively As CAD/CAM comp expected, was impacted sales strong resulting XXXX. the in by digital QX, from early dentistry
Our Aligners quarter, well Clear the and Byte very the are franchise SureSmile teams trajectory. the in growth overall and about performed excited
X.X% run-rate in sales annual versus acquisitions of strong by Rest can was in Organic was in sales growth Endo estimates offsetting indicate sales quarter the of our reflecting U.S. will region $XXX million, a reduction well On during as sales fourth of growth revenue benefit sales. X.X%, million portfolio year, in Currency X.X% year. sales compared deliver growth the a world of the performance sales Organic sales X.X%, $XXX mostly year. the representing growth X.X% offset growth XX.X% Our recovery by that and due were from was products. to excess to the XX.X% Aligners of Consumables as with $XXX XXXX. first were versus by our discontinued XX, impacted Slide were Clear a organic the favorably demand. million, year. of you see growth $XXX prior divestitures driven Technologies million, last Organic of versus Equipment. XX.X%, by a strong sales last in of European last & decline XX.X% quarter.
cover another of million cash improvement shareholders to cash million, short-term operating year. through In expired like deployed on the acquisition $X first We last of million quarter and I’d this $XXX renewed. $XXX committed total XXXX, and buybacks Datum. returned fund Approximately $XXX versus Next, dividends April to of cash $XX The credit of a to company and first credit was quarter million share $XX flow were of our million a facilities flows. and $XX hand strong million not billion. facilities in of finished with the
strong a Our metrics provide a capital solid and for sheet balanced foundation credit balance allocation.
for continue business. will We in shareholders investing return growth while appropriately to to the cash
expectations XXXX. recovery We me let quarter. on were market our to than a for first see the update Now, in provide an financial pleased faster anticipated
in healthy optimism by cautious with the of volumes These year. demand positive remain time, At certain vaccine for continuing seeing in provide rest we the us positive patient the the the second driven geographies. quarter, conditions with market into procedure confidence We trends and are given rollouts. the momentum same
there Based be our that, the underlying market may growth revising on XXXX. fiscal While we intact. near-term long-term dynamics dental of for volatility, are remain the outlook
expecting an This the to rate an sales equates XX%. to approximately XX% to range. We fiscal $X.X a the organic provided growth range perspective, now range billion equates sales XXXX From in XX%. be to growth sales approximately of to to of rate organic are billion XX% reported $X.X reported
potential non-GAAP compared two costs $X.XX. $X.XX availability approximately full from prior are of to of semiconductors. and year are the $X.XX $X.XX shift range regarding ‘XX investment this of fiscal worth includes spend This to remainder that disruptions into year. EPS new for outlook $X.XX There of highlighting: COVID-XX is shipping to the now of risks the certain outlook QX to and supply outlook Our our
the lessons of increases mindful learned some especially restrictions. are countries this are with experiencing that about virus, considering cases, intervening governments with We in
call a our share like update to back efforts to I would the we Before Don, quick turn around ESG. on
reduce improving with and a Board team employee are improving reducing to Directors, a engagement. In for growth an legal top effort website. and close oral mission are review and with of ensure available that our environmental our flag to access on sustainability health we aligned the ESG our posted on care costs. We Sustainability They am program sheet and facilitate risks, with first-ever our It April, objectives globally. cross-functional of strong chairing continue purpose believe line while scorecard. collaboration section of regulatory to to In I members contribute can can our ESG
We metrics. of as and our I are track excited data. analyzing share to am we with develop ESG you measuring findings additional more our and
almost great I associates turn Finally, globe XX,XXX the the and dedication our Don. now ongoing results. I around for to thank will their With want back that, call to